208 related articles for article (PubMed ID: 17655957)
21. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
22. Rapid detection of vancomycin-non-susceptible Staphylococcus aureus using the spiral gradient endpoint technique.
Doddangoudar VC; O'Donoghue MM; Boost MV; Tsang DN; Appelbaum PC
J Antimicrob Chemother; 2010 Nov; 65(11):2368-72. PubMed ID: 20851816
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
[TBL] [Abstract][Full Text] [Related]
24. Reduced susceptibility of Staphylococcus aureus to vancomycin--a review of current knowledge.
Paterson DL
Commun Dis Intell; 1999 Mar; 23(3):69-73. PubMed ID: 10323037
[TBL] [Abstract][Full Text] [Related]
25. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains.
Drummelsmith J; Winstall E; Bergeron MG; Poirier GG; Ouellette M
J Proteome Res; 2007 Dec; 6(12):4690-702. PubMed ID: 17997515
[TBL] [Abstract][Full Text] [Related]
26. Erroneous reporting of vancomycin susceptibility for Staphylococcus spp. by Vitek software version 2.01.
Behera B; Mathur P
Jpn J Infect Dis; 2009 Jul; 62(4):298-9. PubMed ID: 19628909
[TBL] [Abstract][Full Text] [Related]
27. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S136-40. PubMed ID: 16271057
[TBL] [Abstract][Full Text] [Related]
28. Key considerations in the treatment of complicated staphylococcal infections.
Jones RN
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
[TBL] [Abstract][Full Text] [Related]
29. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
Alós JI; García-Cañas A; García-Hierro P; Rodríguez-Salvanés F
J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338
[TBL] [Abstract][Full Text] [Related]
30. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.
Kosowska-Shick K; Ednie LM; McGhee P; Smith K; Todd CD; Wehler A; Appelbaum PC
Antimicrob Agents Chemother; 2008 Dec; 52(12):4510-3. PubMed ID: 18838583
[TBL] [Abstract][Full Text] [Related]
31. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility to manuka honey of Staphylococcus aureus with varying sensitivities to vancomycin.
Jenkins R; Wootton M; Howe R; Cooper R
Int J Antimicrob Agents; 2012 Jul; 40(1):88-9. PubMed ID: 22580029
[No Abstract] [Full Text] [Related]
33. Vancomycin-resistant Staphylococcus aureus in the clinic: not quite armageddon.
Bush K
Clin Infect Dis; 2004 Apr; 38(8):1056-7. PubMed ID: 15095206
[No Abstract] [Full Text] [Related]
34. Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management.
Lewis JS; Ellis MW
Curr Opin Infect Dis; 2007 Dec; 20(6):568-73. PubMed ID: 17975405
[TBL] [Abstract][Full Text] [Related]
35. Increased tolerance of Staphylococcus aureus to vancomycin in viscous media.
Kostenko V; Ceri H; Martinuzzi RJ
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):277-88. PubMed ID: 17727657
[TBL] [Abstract][Full Text] [Related]
36. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
37. Development of a rapid assay methodology for antimicrobial susceptibility testing of Staphylococcus aureus.
Koskinen JO; Stenholm T; Vaarno J; Soukka J; Meltola NJ; Soini AE
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):306-16. PubMed ID: 18707840
[TBL] [Abstract][Full Text] [Related]
38. [Staphylococcus haemolyticus with reduced susceptibility to vancomycin isolated from a patient with neonatal meningitis in a Mexican medical facility].
Reyna-Figueroa J; Ramírez-Landin A; Villeda-Gabriel G; Ortiz-Ibarra FJ
Gac Med Mex; 2007; 143(2):163-5. PubMed ID: 17585704
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the AdvanDx VRE EVIGENE assay for detection of vanA in vancomycin-resistant Staphylococcus aureus.
Fosheim GE; Carey RB; Limbago BM
J Clin Microbiol; 2007 May; 45(5):1611-3. PubMed ID: 17344366
[TBL] [Abstract][Full Text] [Related]
40. [Antimicrobial susceptibility and resistance patterns of Staphylococcus aureus isolated from patients and carriers in Valdivia city, Chile].
Otth R L; Wilson Sch M; Bustamante H N; Fernández J H; Otth L C
Rev Chilena Infectol; 2008 Jun; 25(3):175-8. PubMed ID: 18580993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
